Introduction: Prolactinomas are the most common hormone-secreting pituitary tumors,
accounting for approximately 40% of all pituitary tumors. Infertility, gonadal and sexual …

New information has been provided over the last years regarding treatment of prolactinomas
and will be reviewed in this update. Medical treatment with a dopamine agonist (DA) …

Hyperprolactinemia can be caused by pituitary tumors arising from lactotroph cells, so-called
prolactinomas, but may also develop as a result of pharmacological or pathological …

Prolactinomas are the commonest form of pituitary neuroendocrine tumor (PitNET),
representing approximately half of such tumors. Dopamine agonists (DAs) have traditionally …

Prolactinomas account for approximately 50% of all pituitary adenomas coming to medical
attention and are an important cause of hypogonadism and infertility. The ultimate goal of …

Prolactinoma is the most frequent pituitary adenoma type, accounting for 40–66% in
epidemiological studies [1]. The estimated prevalence in various populations ranges from …

Prolactinomas, the most prevalent type of neuroendocrine disease, account for
approximately 40% of all pituitary adenomas. The most important clinical problems …

Prolactinomas are pituitary tumors that originate from the adenohypophysis lactotroph cells.
These tumors constitute one third of all pituitary adenomas, making them the most common …

The authors present an update on the various treatment modalities and discuss
management strategies for prolactinomas. Prolactinomas are the most common type of …

Introduction: Prolactinomas are unique tumors that may go into both hormonal and
radiographic remission with dopamine agonist therapy or transsphenoidal surgery …